British doctors successfully tested a bowel cancer vaccine
World
Researchers from the Royal University of Surrey in the UK have tested a bowel cancer vaccine on patients from the UK and Australia. The drug will be available for widespread use in as little as two years, which could reduce the need for surgery for patients, the Daily Mail reported.
The treatment involves administering three doses of the drug at fortnightly intervals. According to doctors, this will help "train" the body's immune system to fight cancer. If successful, this approach could avoid the need for surgical removal of the tumour and also reduce the risk of cancer recurrence in the future.
Medics believe the vaccine can successfully eliminate stage 2 and 3 cancers in a group of 44 patients on whom the drug was tested. Currently, there are drugs that target cancer cells, but most patients have to take them continuously. It is thought that a vaccine may be more effective and more convenient for patients.
The researchers are confident that if successful, the drug could be licensed for use in clinics within two years.
Medics believe the vaccine can successfully eliminate stage 2 and 3 cancers in a group of 44 patients on whom the drug was tested. Currently, there are drugs that target cancer cells, but most patients have to take them continuously. It is thought that a vaccine may be more effective and more convenient for patients.
The researchers are confident that if successful, the drug could be licensed for use in clinics within two years.
Powered by Froala Editor